Drug Policy in Greece

ConclusionsThe pricing and reimbursement decision-making processes are centralized under the competence of the MoH. Despite the good intentions of the reformers, there are still some aspects of transparency, equity, and long-term sustainability that remain under question in Greece.
Source: Value in Health Regional Issues - Category: International Medicine & Public Health Source Type: research